ICUI
ICU MEDICAL INC/DE
-1.03 (-0.67%)154.59USD56.3K成交股數3.9B市值129.9本益比(近四季)1.8股價營收比+0.5%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 552M-9% | 530M-16% | 537M-9% | 549M-8% | 605M+7% | 630M+14% | 589M+7% | 596M+5% | 567M | 553M | 549M | 569M |
| 營業成本 | 317M | 324M | 336M | 341M | 395M | 403M | 384M | 389M | 381M | 369M | 357M | 377M |
| 毛利 | 235M+12% | 206M-9% | 201M-2% | 208M+0% | 210M+13% | 227M+24% | 205M+7% | 207M+8% | 185M | 184M | 192M | 192M |
| 毛利率 | 42.6% | 38.9% | 37.4% | 37.9% | 34.7% | 36.1% | 34.8% | 34.8% | 32.7% | 33.2% | 35.0% | 33.8% |
| 研發費用 | 22.7M | 21.3M | 21.3M | 21.9M | 23.3M | 22.4M | 21.0M | 23.4M | 21.8M | 20.9M | 22.3M | 19.8M |
| 銷售管理費用 | 152M | 155M | 153M | 159M | 157M | 159M | 163M | 160M | 158M | 149M | 151M | 153M |
| 營業利益 | 39.1M+204% | 13.6M-64% | 13.7M+67% | 10.6M+38% | 12.9M-221% | 37.7M+65% | 8.2M+198% | 7.7M-18% | −10.7M | 22.9M | 2.8M | 9.4M |
| 營業利益率 | 7.1% | 2.6% | 2.6% | 1.9% | 2.1% | 6.0% | 1.4% | 1.3% | -1.9% | 4.1% | 0.5% | 1.7% |
| 稅後淨利 | 19.1M-223% | 30.1M-226% | −3.4M-90% | 35.3M-265% | −15.5M-61% | −23.8M-429% | −33.0M+232% | −21.4M+118% | −39.5M | 7.2M | −9.9M | −9.8M |
| 淨利率 | 3.5% | 5.7% | -0.6% | 6.4% | -2.6% | -3.8% | -5.6% | -3.6% | -7.0% | 1.3% | -1.8% | -1.7% |
| 稀釋 EPS | 0.76-221% | 1.20-224% | -0.14-90% | 1.43-263% | -0.63-61% | -0.97-423% | -1.35+229% | -0.88+115% | -1.63 | 0.30 | -0.41 | -0.41 |
| 稀釋股數 | 25.0M | 25.2M | 24.7M | 24.7M | 24.5M | 24.4M | 24.4M | 24.4M | 24.2M | 24.4M | 24.1M | 24.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 298M | 288M | 300M | 300M | 290M | 309M | 313M | 303M | 251M | 197M | 196M | 221M |
| 應收帳款 | 184M | 201M | 192M | 179M | 171M | 183M | 174M | 152M | 145M | 162M | 162M | 139M |
| 存貨 | 607M | 606M | 622M | 616M | 590M | 585M | 692M | 683M | 693M | 760M | 775M | 748M |
| 總資產 | 4.0B | 4.0B | 4.1B | 4.1B | 4.2B | 4.2B | 4.3B | 4.3B | 4.3B | 4.4B | 4.5B | 4.5B |
| 有息負債 | 1.2B | 1.3B | 1.3B | 1.3B | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 2.2B | 2.1B | 2.1B | 2.1B | 2.0B | 2.0B | 2.0B | 2.0B | 2.1B | 2.1B | 2.1B | 2.1B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −914M | −973M | −1.0B | −1.0B | −1.2B | −1.2B | −1.2B | −1.3B | −1.3B | −1.4B | −1.4B | −1.4B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 38.9M | – | – | 51.3M+12% | – | – | – | 45.8M | – | – | 41.2M |
| 資本支出 | – | 11.3M | – | – | 14.6M | – | – | – | 15.9M | – | – | 14.2M |
| 自由現金流 | – | 27.6M | – | – | 36.7M+23% | – | – | – | 29.9M | – | – | 27.0M |
| 折舊攤銷 | – | 50.0M | – | – | 49.4M | – | – | – | 55.5M | – | – | 55.7M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 5.2% | – | – | 6.1% | – | – | – | 5.3% | – | – | 4.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 2.2B
| 美國 | 1.4B | 60.8% | -11.5% |
|---|---|---|---|
| 歐洲中東非洲 | 412M | 18.5% | +4.6% |
| 亞太 | 233M | 10.4% | 0.0% |
| Otherforeigncountries | 231M | 10.3% | +3.1% |
產品／服務2025 年度 · 1.1B
| Infusion Systems | 684M | 61.0% | +4.9% |
|---|---|---|---|
| Vital Care | 438M | 39.0% | -36.6% |
| Infusion Consumables 小計 | 1.1B | 98.8% | +6.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.2B | -6.3% | 732K | 0.0% | 0.03 | 91.8M |
| FY2024 | 2.4B | +5.4% | −118M | -4.9% | -4.83 | 125M |
| FY2023 | 2.3B | -0.9% | −29.7M | -1.3% | -1.23 | 82.3M |
| FY2022 | 2.3B | +73.2% | −74.3M | -3.3% | -3.11 | −152M |
| FY2021 | 1.3B | +3.6% | 103M | 7.8% | 4.74 | 199M |
| FY2020 | 1.3B | +0.4% | 86.9M | 6.8% | 4.02 | 131M |
| FY2019 | 1.3B | -9.6% | 101M | 8.0% | 4.69 | 4.6M |
| FY2018 | 1.4B | – | 28.8M | 2.1% | 1.33 | 67.5M |